You are currently browsing the archives for the life science funding category.

Archive for the ‘life science funding’ Category

Is a financial crisis in the cards for American scientists?

 :: Posted by American Biotechnologist on 11-23-2011

GenomeWeb Daily News is reporting that a dozen Congressional leaders tasked with striking a bipartisan agreement to cut the federal deficit said yesterday that they have failed to reach a deal, and that failure would now trigger a plan that would, if enacted, cut research funding across the government by nearly 8 percent.

What impact do you believe this might have on your research activities?

Click here to read more.

New rules affect over 40,000 science researchers

 :: Posted by American Biotechnologist on 08-25-2011

This past week the NIH announced that it was tightening its rules on financial conflict of interest for researchers receiving funding from drug and medical device companies. The new rules include the following revised regulations:

  • Require investigators to disclose to their institutions all of their significant financial interests related to their institutional responsibilities.
  • Lower the monetary threshold at which significant financial interests require disclosure, generally from $10,000 to $5,000.
  • Require institutions to report to the PHS awarding component additional information on identified financial conflicts of interest and how they are being managed.
  • Require institutions to make certain information accessible to the public concerning identified SFIs held by senior/key personnel.
  • Require investigators to complete training related to the regulations and their institution’s financial conflict of interest policy.

According to the Washington Post, there are over 40,000 scientists who currently receive more than $5,000 in annual funding from the drug and medical device industries.

Despite the NIH’s move towards increasing financial transparency, not all watchdog groups are happy with the measure.

To read more on this story see the Washington Post article and the associated press release from the NIH.

Money available for studying Diabetes

 :: Posted by American Biotechnologist on 08-10-2011

GenomeWeb News is reporting that the National Institute of Diabetes and Digestive and Kidney Diseases will award up to $15 million next year in grants to fund Diabetes Research Centers that will conduct a range of ‘omics-based and other interdisciplinary and translational research efforts.

Click here for more.

Your opportunity to influence NIH funding

 :: Posted by American Biotechnologist on 07-27-2011

Rarely do scientists get an opportunity to influence the funding direction of the largest granting agency in the United States, the National Institute of Health. Yet that is exactly what we are being asked to do in the NIH’s latest request for information.

The NIH is requesting that the scientific community send in its ideas on how best to support or accelerate neuroscience research. Responses should address:

  1. areas of neuroscience research that could be accelerated by the development of specific research resources or tools
  2. major opportunities for, and impediments to, advancing neuroscience research
  3. the 2-3 highest priority tools or resources needed to capitalize on the scientific opportunities and overcome obstacles to progress in neuroscience research
  4. how NIH Blueprint might best facilitate the development of these tools/resources

Your answers could influence where neuroscience funding is directed over the next couple of years so be sure to checkout the NIH website to add your two cents!

Raising Scientific Funds the Amazon Way

 :: Posted by American Biotechnologist on 07-13-2011

There was an interesting story in the NY Times the other day which was picked by GenomeWeb’s The Daily Scan regarding a couple of biologists who have turned to non-traditional sources of funding to partially fund their research experiments.

The scientific duo from the Robert J. Bernard Biological Field Station in Claremont, Calif, have raised close to $5,000 from online sales of t-shirts and trading cards which will pay for their lab equipment and travel expenses required to conduct their studies in Mexico. While this level of funding certainly would not be sufficient for even the smallest molecular biology lab, their funding methodology is unique and I believe that they should be commended for their resourcefulness.

As we have mentioned in the past, non-peer reviewed fundraising is not entirely new to the biological research community. In a post written several months ago, we told you how the Kanzius foundation is on its way to raising $250,000 through a Facebook campaign. We also told you about the Search for Research campaign promoted on BenchFly which helps raise money for research using a search engine advertizing strategy.

We all hate writing grants and although non-traditional fundraising efforts will not replace traditional sources of funding any time soon, it is still fun to hear about the different activities people are willing to try in order to fund their research.

What “out of the box” fundraising efforts have you come across?